Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication.This list is provided as a service to readers;inclusion does not imply endorsement by the HBPD INT.

Section editor

Shui-Ying Lei

Email:hbpdje@gmail.com

October

October 17-20,2012; Ankara,Turkey

The congress will be held with international participation in Ankara/Turkey between October 17-20,2012 at Sheraton Hotel & Convention Center.It is aiming to supply all participants with the latest academical and technological developments in the field by our national& international invited speakers and sponsors.For more information,please contact:Congress Secretariat,Prof.Aydin Yagmurlu,Ankara University Pediadric Surgery,eayagmur@medicine.ankara.edu.tr; or Organization,Burak Akicier,BSBMIC,info@bsb.com.tr.Website:http://english.cocukcerrahisi2012.org/index.php?

The 2nd world congress on controversies in the management of viral hepatitis (C-Hep)

October 18-20,2012; Berlin,Germany

The 2nd C-Hep Congress will be held in Berlin,Germany on October 18-20,2012.The C-Hep Congress attempts to summarize all the key new data recently presented and how it might be implemented in routine care of hepatitis B and C patients.Overviews,state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients,including the appropriate use of new drugs.This educational Congress focuses on clinical practices in viral hepatitis and benefits not only hepatologists and infectious diseases specialist,but also general practitioners,internists and primary care physicians with a desire to gain knowledge in these exciting advances.The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts.Participants are encouraged to take an active role in the discussions with faculty members which follow each debate,in a unique and open environment.For more information,please visit:http://comtecmed.com/chep/2012/Default.aspx.

20th united European gastroenterology week

October 20-24,2012; Amsterdam,Netherlands

The congress is organized by the United European Gastroenterology Federation.For more information,please contact:UEGF Secretariat,Wienerbergstr.11/12A,1100 Vienna,Austria.Tel:43-1-997-16-39; Fax:43-1-997-16-39-10;Email:office@uegf.org.Website:www.uegf.org.

13th Asia-Pacific congress on clinical microbiology and infection

隨著信息化時代的到來，我國的氣象現(xiàn)代化進(jìn)程在也出現(xiàn)了新的發(fā)展契機(jī)，尤其是氣象觀測取得了一定程度的進(jìn)展。大數(shù)據(jù)時代的到來為氣象檔案的管理提供了發(fā)展的空間。利用大數(shù)據(jù)等現(xiàn)有的設(shè)備和技術(shù)促進(jìn)氣象數(shù)據(jù)的安全性，同時提高管理的能力已經(jīng)成為氣象部門必須面臨的問題。本文闡述的主要內(nèi)容是大數(shù)據(jù)環(huán)境氣象檔案管理中存在的一些問題。

October 25-28,2012; Beijing,China

The congress is hosted by Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI,formerly WPSC).The chairman of this congress is Prof.Lan-Juan Li,Zhejiang University School of Medicine,Hangzhou,China.The congress is to provide the channels to demonstrate and share the progress that all specialists have achieved,link resources in chemotherapy and infectious diseases.For more information,please contact:Congress Secretariat (China),Beijing MedConference Service Co.,Ltd.,Ms.Xiao-Xue Bian,Room 510,B tower,Free Town Center,No.58,Dongsanhuan Rd.,Chaoyang District,Beijing 100022,China.Tel:86-10-67122288ext274; Fax:86-10-67160676; Email:bianxiaoxue@mpco.cn.Website:http://www.apccmi 2012.org/index.html.

November

24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics

November 6-9,2012; Dublin,Ireland

The 24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics will take place from November 6-9 2012 at Dublin,Ireland.Hosted by the European Organisation for Research and Treatment of Cancer,the National Cancer Institute and the American Association for Cancer Research,the 2012 symposium will bring together over 2000 academics,scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development,target selection and the impact of new discoveries in molecular biology.For more information,please visit:http://www.ecco-org.eu/Home/Conferences/Conferences/EORTC_NCI_AACR%202012.aspx.

Post-GWAS Horizons in molecular epidemiology:digging deeper into the environment

November 11-14,2012; Westin Diplomat Resort,Hollywood,FL,USA

Genome-wide association studies (GWAS) have brought forth a vast amount of information on genetic risk factors for cancer.The conference will showcase and discuss new areas of research in molecular epidemiology,focusing on the integration of novel measures of internal and external environmental factors in consortia and genetic studies.Research findings will be presented to illustrate the vast potential within the context of epidemiologic studies in a post-GWAS context to further the prevention of cancer and elucidate mechanisms of carcinogenesis.Large-scale publicly-available research resources will be highlighted and their "rules to play"discussed.Late-breaking findings from genomics,epigenomics,and proteomics in epidemiologic studies will be presented with a view to discern the most promising strategies with the greatest public health impact.For more information,please visit:http://www.aacr.org/home/scientists/meetings--workshops/special-conferences/post-gwas-horizons-in-molecularepidemiology.aspx.

Translational cancer research for basic scientists

November 26-December 1,2012; Hilton Boston Back Bay,Boston,MA,USA

This workshop is hosted in close collaboration with the Dana-Farber Cancer Institute/Harvard Cancer Center,comprised of Beth Israel Deaconess Medical Center,Brigham and Women's Hospital,Children's Hospital Boston,Dana-Farber Cancer Institute,Harvard Medical School,Harvard School of Public Health and Massachusetts General Hospital.The Translational Cancer Research for Basic Scientists Workshop will provide basic research scientists with a better understanding of translational research,teach them how to adapt their research for maximum clinical impact,and help them transition into a new career in translational cancer medicine.This innovative workshop addresses many aspects of translational research including leading multidisciplinary teams,working collaboratively and effectively with industry partners,recognizing the unique needs and environment of the clinic and clinical laboratories,dealing with the regulatory and compliance issues in translational science,and understanding the perspective of the patient in order to place research questions into a broader context.During the course of the week,attendees will gain perspective and background knowledge of the disease from translational scientists in academia and industry,clinicians and patients,while learning about the latest methods and approaches in cutting-edge translational cancer research.For further information,please contact Lyngine Calizo,PhD,program administrator,at (215)446-7265 or lyngine.calizo@aacr.org.

December

Tumor immunology:multidisciplinary science driving basic and clinical advances

December 2-5,2012; Inter Continental Miami Hotel,Miami,Florida,USA

Conference co-chairpersons are Profs.Elizabeth M.Jaffee,Sidney Kimmel Cancer Center at Johns Hopkins,Baltimore,MD; Stanley Riddell,Fred Hutchinson Cancer Research Center,Seattle,WA; and Glenn Dranoff,Dana-Farber Cancer Institute,Boston,MA.The central theme of this conference is to present and discuss the rapidly developing advances in basic and translational tumor immunology.Central to this theme will be updates on the immunologyfield's adoption of new technologies in molecular biology,proteomics,engineering,and imaging that are providing novel insights into the cytokine/chemokine,receptor:ligand checkpoint,genetic,and epigenetic regulatory pathways that in fluence the in flammatory changes that are critical to cancer development and progression.In addition,this conference will highlight new advances in targeting these pathways for cancer prevention and treatment.The conference will bring together cancer immunologists and clinical researchers in the field with a broad focus that will include advances in basic immunologic principles and new approaches for the treatment and prevention of different cancers.Attendees will include cancer immunologists and nonimmunologists who are applying new technologies and concepts aimed at dissecting the in flammatory and immune responses that contribute to cancer development and progression.Building on AACR's previously successful Cancer Immunology Special Conferences,it is expected that this conference will provide for highly stimulating discussions that will further the scientific and translational goals of the field and allow for more effective exchange between cancer immunologists and scientists in otherfields with expertise that can be applied to cancer immunology.For more information,please visit:http://www.aacr.org/home/scientists/meetings--workshops/specialconferences/tumor-immunology-multidisciplinaryscience-driving-basic-and-clinical-advances.aspx.